(1) In respect of the prohibition of Salvinorin A by the National Drugs and Poisons Schedule Committee, under what full name was the substance first prohibited.

(2) Was this name later corrected; if so, in what way.

(3) What was the original source of the incorrect name given for that substance.

(4) Is that source the subject of any prohibition or classification under the guidelines of the Office of Film and Literature Classification.

(5) Is the government now certain that the full correct name of the substance is correct.

(1) The full chemical name for Salvinorin A initially adopted by the National Drugs and Poisons Schedule Committee (NDPSC) and included in Schedule 9 of the Standard for Uniform Scheduling of Drugs and Poisons (SUSDP) was 8-METHOXYCARBONYL-4A,8A-DIMETHYL-6-ACETOXY-5-KETO-3,4,4B,7,9,10,10A-SEPTAHYDRO-3-(4-FURANYL)- 2,1-NAPHTHO[4,3-E]PYRONE.

(2) The NDPSC subsequently corrected the chemical name for Salvinorin A in Schedule 9 of the SUSDP to METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10-DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7-CARBOXYLATE when it became known that the original chemical name was in error. This change is on the public record as the Schedule 9 amendment was published in the Commonwealth of Australia Gazette No GN 49 on 11 December 2002 with the basis for the decision included in the record of the reasons for the October NDPSC 2002 meeting on the Therapeutic Goods Administration website.

(3) and (4) NDPSC records do not identify the exact source of the incorrect chemical name for Salvinorin A.

(5) Yes, the chemical name for Salvinorin A listed in Schedule 9 of the SUSDP No. 18 meets the SUSDP definition of an approved name.